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Introduction 
Most organic drug compounds are aromatic heterocycles; their systematic study and 
manufacturing started at the beginning of the 20th century. It is interesting that the preparation 
of the saturated heterocyclic derivatives began only fifty years later. Clarification of the 
theoretical background of stereoisomerism and investigation of the stereoisomers of saturated 
molecules commenced only after the appropriate analytical equipment became available. 
One of the advantages of the use of saturated heterocycles as drug compounds is that 
the heteroaromatic compounds and their biotransformation products are sometimes toxic. The 
saturated analogues which were not investigated until the 1970s, and especially those which 
contain heteroatoms in the 1,3 positions, have essentially lower toxicity.9 Since 1979, Bernâth 
and his co-workers have been working on the synthesis and conformational analysis of fused-
skeleton fully or partly saturated heterocyclic compounds at the Institute of Pharmaceutical 
Chemistry at the University of Szeged. 
The syntheses of the saturated analogues of condensed aromatic compounds do not 
simply involve application of the reactions characteristic of the aromatic compounds. The 
saturated heterocycles can frequently be prepared by different methods and they mostly react 
in different ways. On cyclization, new chiral centres are formed on the saturated sp3 carbon 
atoms. Hence, for the preparation of structural isomers, e.g. stereohomogeneous cis and irons, 
exo and endo compounds, either stereoselective reactions have to be applied, or the 
stereoisomers formed (mostly diastereomers) have to be separated by appropriate methods. 
We have recently often used cis and trans, exo and endo starting materials, or 
separated the isomeric compounds in the early stages of preparation. In the course of our 
work, when possible, we applied sterically controlled reactions and separated the resulting 
isomers by chromatographic methods, which resulted in stereohomogeneous cis and trans, 
exo and endo products. The structures of the isomers (conformation and configuration) were 
established by IR and NMR spectroscopy, or X-ray methods were also used for structure 
elucidation. On the basis of these investigations, correlations could be established between the 
stereostructure and the pharmacological activity. 
5 
Literature review 
The preparations of c/'s-trimethylene-, cis- and iram-tetramethylene- or penta-
methylene-dihydro-l,3-oxazines,10 the analogous tetrahydro-l,3-oxazines,11-12 l,3-oxazine-2-
ones,13-14 l,3-oxazine-2-thiones,15-16 l,3-oxazine-4-ones17-18 and related condensed heterocyclic 
compounds, such as the pyrimidone derivatives,19 have been published from the Institute. The 
stereostructures of these compounds were established by means of 'H and 13C NMR 
spectroscopy and in some cases X-ray diffraction studies.10-15-20 The homologous cis and trans 
isomers mentioned above were synthesized for systematic pharmacological study. 
In the course of the research on fused 1,3-oxazine derivatives, numerous 1,3-oxazine 
derivatives containing a norbornane or norbornene skeleton were prepared.21"25 Although the 
norbornane moiety itself is rarely found in natural compounds, its trimethyl derivatives are 
common, for isoprene (containing five carbon atoms) is a starting unit in the biosynthesis of 
mono and higher terpenes. 
The norbornane skeleton often occurs among synthetic drugs. A review published in 
1983 describes hundreds of norbornane derivatives as therapeutically active compounds,26 e.g. 
the Propranolol analogue P-receptor-blocker Bornaprolol27 (Scheme 1), which acts for a long 
time because of the slow dissociation of the drug complex.28 Noreximide is a stimulant of the 
central nervous system.29 Some of the 5-fluorouracil derivatives, e.g. l-[7V-(3-amino-2-nor-
bornyl)carbamoyl]-5-fluorouracil, have an anticarcinogenic effect.30 Norbornane derivatives 
Propranolol Bornaprolol Noreximide l-[A-(3-amino-2-norbornyl)-
(Stobetin®) (diexo-diendo mixture) carbamoyl]-5-fluorouracil 
Scheme 1 
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are used not only as potential pharmacons, but also as herbicides, insecticides, etc. 
One of the reasons for my work was that 2-/w-chlorophenyl-c/s-5,6-trimethylene-4-
pyrimidone, synthesized by Bernáth et ál., exhibits outstanding analgetic and anti-inflamma-
tory activity, and was chosen by Chinoin Pharmaceutical Co. under the notation CHINOIN 
14331 for further development (Scheme 2). 
CHINOIN 143 
G. Bernáth, L. Gera, Gy. Göndös, M. Hermann, 
M. Szentiványi, Z. Ecsery, E. Janvári, Ger. Pat. 2643384 
(1977); ref. Chem. Abstr. 87, 168078b (1977) 
Scheme 2 
It could be expected that the norbornane and pyrimidinone moieties together would 
give an effective structure, especially when the annelation is cis. 
Stájer et al. have synthesized a large number of norbornane- and norbornene-conden-
sed heterocycles for pharmacological purposes. These are ethylene-bridged or ethenylene-
bridged derivatives of the trimethylene-condensed heterocycles in their cyclopentane ring.313-25 
Two isomeric series of these compounds containing rigid carbobicycles have been prepared: 
the endo-endo and exo-exo derivatives. 
I joined in the work on the preparation of pharmacologically active compounds in 
1981. Initially, I took part in the synthesis and structure establishment of 1,3-oxazines, and 
dealt later with the separation of isomers obtained on a semipreparative scale by HPLC. 
Recently, I have been working at EGIS Pharmaceutical Co. on pharmacological and 
pharmacokinetic studies of compounds chosen, e.g. deramciclane, which contains a norbor-
nane skeleton, and have participated in the structure investigation of its metabolites. 
N C6H ,C1(M) 
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Results 
1. Synthesis and conformational study of partially saturated 1,3-benzoxazines, 1,3-
benzoxazine-2-ones and l^-benzoxazine-l-thiones1 
The starting aminoalcohol (1) was prepared by acidic hydrolysis of the cycloadduct of 
norbornene (2) and jV-hydroxymethylbenzamide.32"34 The yield of 2-exo-hydroxy-3-i?xo-ami-
nomethylbicyclo[2.2.1]heptane (1) was low, however: 15%. 
O 
Ph-^NPK^-OH 
AcOH 
Ph 
Scheme 3 
For a higher yield and to prepare the unsaturated aminoalcohol (5), trichloroacetyl 
isocyanate was used34 (Scheme 4). Hydrolysis34 of 2-trichloromethyl-5,8-methano-
4a/\5c,6,7,8c,8ac-hexahydro-4//-l,3-benzoxazine-4-one (7) and 2-trichloromethyl-5,8-
methano-4ar,5c\8c,8ac-tetrahydro-477-l,3-benzoxazine-4-one (8) gave the trichloroacetyl-P-
hydroxy-carboxamides 9 and 10. After removal of the trichloroacetyl group, these furnished 
O 
II 
CljCCNCO 
2 Q: CH2CH2 
6 Q: CH=CH 
7 Q: CH2CH2 
8 Q; CH=CH 
1 Q: CH2CH2 
5 Q: CH=CH 
11 Q: CH2CH2 
12 Q: CH=CH 
9 Q: CH2CH2 
10 Q: CH=CH 
-CONH2 
OCCCK 
Ü 
Scheme 4 
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the saturated and unsaturated 2-hydroxy-l-carboxamides (11 and 12) which were reduced 
with lithium tetrahydridoaluminate(III) (LAH) to 1 and 5; in this way, 40-45% aminoalcohols 
were obtained. 
From 1 and 5, the carbamates 13 and 14 were prepared with ethyl chloroformate, and 
were cyclized to 5,8-methano-4ar,5c,6,7,8c,8ac-hexahydro-4//-l,3-benzoxazine-2(3//)-one 
(15) and 5,8-methano-4ar,5c,8c,8ac-tetrahydro-4//-l,3-benzoxazine-2(3//)-one (16) 
(Scheme 5). The thiones 20-22 were prepared from 1, 5 and 24 through the dithiocarbamates 
17-19 (not isolated) by cyclization with Pb(II). 
On oxidation of carboxamide 11 with chromic acid35,36, the P-oxo-carboxamide 23 was 
obtained (Scheme 6), which was reduced to the t//c»t/o-P-hydroxycarboxamide 25 with 
NaBH4. Direct reduction of the carboxamide 23 to the stereohomogeneous aminoalcohol 24 
with LAH was not successful because the 1:1 mixture of diendo-diexo derivatives was 
obtained. However, reduction of the p-hydroxycarboxamide 25 with LAH gave the stereo-
homogeneous diendo-aminoalcohol (24). 
O 15 Q: CH2CH2 
16 Q: CH=CH 
20 diexo, Q:CH2CH2 
21 diexo, Q: CH=CH 
22 diendo, Q: CH2CH2 
Scheme 5 
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LAH •< 
OH N H 2 
24 25 
Scheme 6 
2,2-Dimethyl-5,8-methano-4a/',5c,6,7,8c,8ac-hexahydro-2//-l,3-benzoxazine-4(3//)-one 
(26), 2,2-dimethyl-5,8-methano-4a^,5c,8c,8a-tetrahydro-2//-l,3-benzoxazine-4(3//)-one (27) 
and 2,2-dimethyl-5,8-methano-4ar,5i,6,7,8/,8ac-hexahydro-2//-l,3-benzoxazine-4(3//)-one 
(28) were obtained by cyclization of the 2-hydroxy carboxamides (11, 12 and 25) with 
acetone (Scheme 7). 2-/?-Chlorophenyl-4a?-,5c,6,7,8c,8ac-hexahydro-l,3-benzoxazine-4(3//)-
one (29), 2-p-chlorophenyl-4a/-,5c,8c,8ac-tetrahydro-27/-l,3-benzoxazine-4(3//)-one (30) and 
2-/>-chlorophenyl-4ar,5/,6,7,8/,8ac-hexahydro-2/M,3-benzoxazine-4(3//)-one (31) were 
prepared from 11, 12 and 25 with aldehyde. 
From the reactions of the aminoalcohols 1 and 24 with imidates, 2-aryl-5,8-methano-
4a/\5c,6,7,8c,8ac-hexahydro-4//-l,3-benzoxazines (32a-d) and 2-aryl-5,8-methano-
4a/',5/,6,7,8/,8ac-hexahydro-4//-l,3-benzoxazines (33a-b) were formed, the 2-phenyl deriva-
tive of which (32a) was already known32 (Scheme 8). 
The 2-aryl-5,8-methano-4ar,5c,8c,8ac-tetrahydro-4//-l,3-benzoxazines (34a-d) were 
prepared from norbornadiene 6 by cycloaddition of A-hydroxymethylbenzamides (Scheme 9). 
In the IR spectra, the carbonyl lines for 15 and 16 were found at 1720-1695 cm'1. The 
vNH bands appear in the region 3450-3170 cm"1; the analogous thiocarbonyl lines for 20-22 
10 
Scheme 7 
lie in the interval 1590-1540 cm'1, and the vNH bands at 3200-3150 cm'1. The amide-1 bands 
of the derivatives 26-31 were found at 1650-1645 cm"1, while the vNH lines appeared in the 
region 3750-3350 cm"1. The characteristic vNH lines were missing from the spectra of 32a-d, 
33a-b and 34a-d; instead, the vN=H lines of a cyclic iminoether could be identified at 1650-
1640 cm'1. 
The annelation of the norbornane moiety and the heterocycle was established by the 
multiplicity of the H-8a proton resonance signal. The dihedral angle H-8-C-8-C-8a-H-8a in 
the diendo compounds 21, 28, 31 and 33a-b is ~50°, while for the diexo analogues it is 
~90°. Thus, for the diendo compounds, the spin-spin coupling of H-8,8a causes a significant 
11 
a: C6H5; b: C6H4Cl(p); c: C6H4C1 (w); d: C6H4CH30) 
Scheme 8 
splitting, whereas in the spectra of the diexo compounds the magnitude of this splitting is 
smaller than 1 Hz.37 The H-8a signal in the spectra of the diexo compounds 15, 16, 20, 21, 26, 
27, 29, 30, 32a-d and 34a-d is a doublet with J = 8 Hz, corresponding to the H-4a,8a 
coupling, while in the spectra of the diendo compounds it appears as a double doublet with 
J = 9.5 and 4.5 Hz; the H-8,8a coupling causes a splitting of about 4 Hz. 
a: R1 = R2= H, b: R1 = CI, R2 = H; c: R1 = H, R2 = CI; d: R1 = CH3, R2 = H 
Scheme 9 
There are significant differences in the H-5 and H-8 chemical shifts of the saturated and 
unsaturated compounds. In the latter group, the -I effect of the C=C group causes a downfield 
shift: the H-5 signal is in the region 2.5-2.9 ppm, while that of H-8 lies at 2.54-3.25 ppm. For 
the norbornanes, the two shift intervals are 2.05-2.25 and 2.05-2.7 ppm, respectively. 
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The signals of the aromatic protons in the 'H NMR spectra appear at 7.2-7.9 ppm, with 
the expected multiplicity and intensity, while there are no proton signals in this region if the 
aromatic substituent is missing. 
The C-2 signals in the 13C NMR spectra are characteristic of the different functional 
groups. The signals of the carbonyl atom C-4 in 26-31 are in the region 170-172 ppm, as 
expected. 
2. Preparation and NMR study of norbornane- and norbornene-fused 2-phenyliniino-
1,3-oxazines and -thiazines2 
As concerns the starting 1,3-aminoalcohols, seven of the possible eight (1, 5, 24 and 
36a-39a) were synthesized; these differ as regards the double bond of the norbornane moiety 
and the positions of the oxygen and nitrogen atoms; three of them (1, 5 and 24) were 
described earlier1,21 (Scheme 10). 
1 5 24 
36a 37a 38a 39a 
Scheme 10 
The ¿//coro-aminoalcohols 36a and 38a were prepared by the cycloaddition38 of 
norbornene 2 or norbornadiene 6 and A-chlorosulphonyl isocyanate (Scheme 11). The N-
chlorosulphonylazetidinones 40 and 41 were reduced with sulphite39 and the 3-exo-4-azaoxo-
cyclo[4.2.1.02,5]nonane (42) and -non-7-ene (43) formed were hydrolysed with HC1.38 After 
purification on an ion-exchange resin, the hydrochlorides of the saturated (44) and the 
unsaturated (45) bicyclic amino acids were obtained.40 By reduction with LAH, 
13 
2 Q: CH2CH2 40 Q:CH2CH2 42 Q:CH2CH2 
36a Q:CH2CH2 44 Q: CH2CH2 
38a Q: CH=CH 45 Q: CH=CH 
Scheme 11 
3-exo-hydroxymethylbicyclo[2.2.1]heptyl-2-exo-amine (36a) and 3-exo-hydroxymethyl-
bicyclo[2.2. l]hept-5-enyl-2-exo-amine (38a) were prepared. 
The diendo analogues were synthesized from the Diels-Alder adduct of cyclo-
pentadiene and maleic acid anhydride41 (Scheme 12). After Hoffmann42 degradation of the 
product obtained by ammonolysis of <7/'e//£/o-norbornenedicarboxylic anhydride (46), the 
reaction mixture was purified on an ion-exchange column, and 2-i?//£/oaminobicyc-
lo[2.2.l]hept-5-ene-3-ew/ocarboxylic acid (47) was isolated and then reduced with LAH to 
obtain the 3-c//i/o-hydroxymethylbicyclo[2.2.l]hept-5-enyl-2-c//t7o-amine (39a). The double 
bond of the ester hydrochloride of the amino acid (48) was saturated with hydrogen in the 
presence of PtCh as catalyst, and the base 50 that was released from the ester salt 49 by 
treatment with Et3N was reduced with LAH to the aminoalcohol 37a (Scheme 12). 
The TV-methyl (36b-39b) and TV-benzyl derivatives (36c-39c) of the aminoalcohols 
(36a-39a) were made from the amino acids43 44 (Scheme 13). The carbamates 56-59 prepared 
from the hydrochlorides of the amino acid esters 48, 49, 51 and 52 with ethyl chloroformate 
were reduced with LAH to give 2-exo-methylaminobicyclo[2.2. l]heptane-3-exo-methanol 
(36b), 2-t?//cTo-methylaminobicyclo[2.2.1]heptane-3-c«r/o-methanol (37b), 2-exomethylami-
nobicyclo[2.2.1]hept-5-ene-3-exo-methanol (38b) and 2-e»i/o-methylamino-bicyclo[2.2.1]-
14 
Scheme 12 
hept-5-ene-3-<?/?£/o-methanol (39b). With benzoyl chloride, the benzamides 60-63 were 
prepared; on subsequent reduction with LAH, these gave the A-benzyl-substituted amino-
alcohols (36c-39c). 
The unsubstituted aminoalcohols and the methyl and benzyl derivatives (36-39) were 
converted with phenyl isothiocyanates into thioureas (64-67) in nearly quantitative yields 
(Scheme 14). On refluxing in EtOH containing 20% HC1,45,46 the thioureas were cyclized to 
the saturated and 6,7-unsaturated diendo- and i//'i?xo-2-phenylimino-5,8-methano-3,1-benzo-
thiazines (68a-c-71a-c). 
However, the acid-catalysed cyclization can follow two reaction paths, since the 
nucleophilic attack of the sulphur on the non-cyclic methylene carbon results in the formation 
of 1,3-thiazines (68-71), whereas the attack of the oxygen of the hydroxythiourea intermedia-
tes 64-67 on the thiocarbonyl carbon leads to the formation of tricyclic l,3-oxazine-2-thiones. 
15 
Two of the latter compounds (72b and 73b) could be isolated besides 68b and 69b; these 1,3-
oxazine-2-thiones were already prepared earlier.43'46 
COOH 
NH-> 
SOCl2 
EtOH 
44 Q:CH2CH2 
45 Q: CH=CH 
COOEt 
iNH^HCl 
51 Q:CH2CH2 
52 Q: CH=CH 
53 Q:CH2CH2 
54 Q: CH=CH 
51 diexo, 
49 diendo, 
52 diexo, 
48 diendo, 
CH2CH2 
CH2CH2 
CH=CH 
CH=CH 
LAH 
56 diexo, 
57 diendo, 
58 diexo, 
59 diendo, 
CH2CH2 
CH2CH2 
CH=CH 
CH=CH 
OH 
NHMe 
36b diexo, Q CH2CH2 
37b diendo, Q CH2CH2 
38b diexo, Q CH=CH 
39b diendo, Q CH=CH 
53 diexo, 
50 diendo, 
54 diexo, 
55 diendo, 
COOEt 
NIL 
Q: CH2CH2 
Q: CH2CH2 
Q: CH=CH 
Q: CH=CH 
PhCOCl. 
COOEt 
60 diexo, 
61 diendo, 
62 diexo, 
63 diendo, 
CH2CH2 
CH2CH2 
CH=CH 
CH=CH 
LAH. 
NHCOPh 
OH 
NHCH2Ph 
36c diexo, Q CH2CH2 
37c diendo, Q: CH2CH2 
38c diexo, Q CH=CH 
39c diendo, Q: CH=CH 
Scheme 13 
Monocyclic 1,3-oxazinethione analogues were prepared in 87% yield by Guseva et 
alA1 by refluxing aliphatic hydroxythioureas in toluene. They assumed amine elimination and 
the formation of an isothiocyanate intermediate. 
From the reactions of the thioureas (64-67) with methyl iodide in the presence of a 
base, isothiuronium salts were prepared, which were cyclized to 1,3-oxazines (74a-c-77a-c).48 
In the case of 77b, the isothiuronium salt intermediate was also isolated. 
The thioureas 78a-c prepared from the isomeric aminoalcohol 1 by treatment with 
isothiocyanates were cyclized with HC1 to the 1,3-oxazines 79a-c (Scheme 15). The acid-
catalysed cyclization gave heterogeneous products. The main oxazine compounds (79a-c) 
16 
were isolated; in contrast with the isomers 68-71, however, the analogous thiazines could not 
be prepared. 
6, 7 
R 
64a-c-67a-c 
Mel/NaOH 
N 
R 
68a-c-71a-c 72b, 73b 74a-c-77a-c 
Compound Isomer R Q 
36a, 64a, 68a, 74a diexo H CH2CH2 
37a, 65a, 69a, 75a diendo H CH2CH2 
38a, 66a, 70a, 76a diexo H CH=CH 
39a, 67a, 71a, 77a diendo H CH=CH 
36b, 64b, 68b, 72b, 74b diexo CH3 CH2CH2 
37b, 65b, 69b, 73b, 75b diendo CH3 CH2CH2 
38b, 66b, 70b, 76b diexo CH3 CH=CH 
39b, 67b, 71b, 77b diendo CH3 CH=CH 
36c, 64c, 68c, 74c diexo /z-tolyl CH2CH2 
37c, 65c, 69c, 75c diendo p-tolyl CH2CH2 
38c, 66c, 70c, 76c diexo p-tolyl CH=CH 
39c, 67c, 71c, 77c diendo /?-tolyl CH=CH 
Scheme 14 
The amino-imino tautomerism of monocyclic 2-imino-substituted 1,3-oxazoles, 1,3-
oxazines, 1,3-thiazoles and 1,3-thiazines has already been studied in detail.49 Depending on 
the phase (solid or solution) investigated, the various methods of examination (IR, 'H and l3C 
NMR and X-ray diffraction) indicated that in some cases the amine, and in other cases the 
17 
imine form predominated.50"56 For thiazoles and thiazine derivatives, the exact ratio of the 
tautomers was recently determined by 15N NMR spectroscopy.57 
Scheme 15 
The norbornenes and norbornanes can easily be recognized from the NMR signals of 
H-6,7 and C-6,7 in the 'H and 13C NMR spectra, respectively. The two double doublets of the 
olefinic protons in the unsaturated compounds, each of 1H intensity, appear between 5.90 and 
6.30 ppm [merged into a singlet of 2H intensity in the cases of 71a and 71b], whereas the 
signals of the methylene protons in the saturated analogues, overlapping those of the group at 
position 9, appear in the region 0.9-1.9 ppm. For the norbornenes, the C-6,7 lines lie between 
134.6 and 140.6 ppm, whereas the signals of the saturated carbon atoms of the norbornane 
compounds appear at 20-30 ppm. 
The thiazines 68-71 and oxazines 72-77 can be identified through the chemical shifts 
of H-4 and C-4. In the 'H NMR spectra of the former compounds, the signals of the non-
equivalent methylene protons appear at 2.4-2.95 ppm, whereas for the latter compounds they 
appear in the region 3 .65-4.30 ppm, as anticipated.59 The regions of the corresponding carbon 
chemical shifts for the two types of compounds, again as expected,59 are at 26.7-31.1 and 
65.5-69.8 ppm, respectively. 
A considerable difference is found as concern the chemical shift of C-2. In the 
thiazines, the adjacent sulphur atom causes a marked downfield shift of the C-2 signal as 
compared with that in the oxazines. The C-2 signal for the thiazines appears at 156.7-160.0 
ppm, whereas for the oxazines (74-77) it lies at 144.5-148.6 ppm. The chemical shift of C-l ' 
18 
(2-phenyl group), however, reveals an opposite effect, though to a lesser extent: it is found in 
the interval 147.1-151.6 ppm for the thiazines and 151.5-1 53.4 ppm for the oxazines. 
The diendo or diexo annelation of the hetero- and carbobicyclic rings is indicated by 
the multiplicity of the H-8a signal in the region 3.0-4.09 ppm. For the diexo compounds, this 
signal is a doublet (J = 7-10 Hz) corresponding to the H-4a,8a coupling, whereas in the 
spectra of the diendo compounds it appears as a double doublet, besides the splitting 
originating from the H-4a,8a spin-spin interaction (the magnitude of which varies in the range 
6.5-12.5 Hz in this series); another significant splitting is observed due to the H-8,8a coupling 
(3-4 Hz). The dihedral angle H-8-C-8-C-8a-H-8a is -50°, whereas that in the diexo 
compounds is -90°, and therefore no splitting can be anticipated37 [J(H-8,H-8a) < 1 Hz].23 
The H-8a chemical shift depends mainly on the annelation: it is 3.01-3.36 ppm for the 
endo H-8a of the diexo series and 3.30-3.95 ppm for the exo H-8a of the diendo compounds, 
in accord with the literature data on norbornane and norbornene. Values of 1.18 and 1.46 ppm 
have been measured for the protons of the former, and 0.96 and 1.59 ppm for those of the 
latter in the endo and exo configurations, respectively.60"62 
This holds for the H-4a signal too: for 70 and 76, the shielding is stronger (1.98-2.23 
ppm) than for the isomers 71 and 77 (2.5-2.8 ppm); similarly, it is stronger for 68 and 
74 (1.98-2.2 ppm) than for 69 and 75 (2.3-2.4 ppm). Again as expected, we found that the 
position of the H-8a signal is also slightly dependent on the saturation of the carbocycle. H-8a 
in the norbornenes is more shielded in the diexo isomers, with chemical shifts of 3.01-3.30 
ppm, while for the norbornanes shifts between 3.10 and 3.36 ppm were observed. For the 
diendo compounds, the chemical shift interval is 3.3-3.6 ppm for norbornanes, whereas for the 
norbornene analogues it is 3.61-3.95 ppm. 
There are significant differences in the H-5,8 chemical shifts of the saturated and 
unsaturated compounds. In the latter group of compounds, the -7 effect of the olefinic group 
causes a downfield shift: the H-5 signal is in the region 2.5-2.9 ppm, while that of H-8 lies at 
2.54-3.25 ppm. For the norbornanes, however, the two shift intervals are 2.05-2.25 and 
2.05-2.7 ppm, respectively. 
In the 13C NMR spectra of the norbornenes, the C-5,8, signals display a downfield 
shift, due to the greater a-effectS9 of the olefinic bond (45.2-8.3 and 46.2-9.5 ppm, respec-
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tively, as compared with the observed values of 39.5-2.1 and 39.6-44.1 ppm, respectively, for 
the norbornanes. 
In the spectra of the norbornanes, the C-4a and C-8a lines are shifted upfield in 
consequence of the steric hindrance between H-6,7 (endo) and the NR. moiety or H-4 (steric 
compression shift: carbons bearing sterically hindered groups are more shielded63). 
For compounds 69 and 75, the mean shift of the C-4a signal is 42.2 and 38.3 ppm, 
respectively; this means a field effect of 5.2 ppm as compared with those in the analogues 68 
and 74 (47.4 and 43.5 ppm, respectively). For the C-8a signal, the mean field effect is 4.1 and 
3.9 ppm. For the norbornenes, the greater distance of the olefinic protons from H-4 and the 
NR. group, results in the disappearance of the field effect; furthermore, for the H-4a signal, an 
opposite, albeit lower (average of 1.9 and 1.3 ppm) shift is observed. Steric hindrance is also 
present in the diexo compounds, but instead of H-6,7 (endo), H-91 (endo) is involved with 
4-CH2 or the NR. group. This is indicated by the large field effect on the C-9 signals, which 
can be observed for both the norbornanes and norbornenes. The average field effects for the 
pairs 70-71, 68-69, 76-77 and 74-75 are 5.1, 4.4, 4.5 and 4.2 ppm, respectively. 
It is noteworthy that endo++exo C=N bond tautomeric equilibrium is possible in the N-
unsubstituted compounds (68a-71a and 74a-77a).. The synthesis route means that the 
corresponding //-substituted series b and c are exclusively isomers substituted on the ring 
nitrogen, containing an exocyclic C=N bond. The fact that neither the chemical shifts of the 
aromatic protons of the 2-phenylimino group, nor those of the carbon atoms in this ring (with 
the exception of C-l1), are altered significantly as compared with those in the 
//-substituted analogues is unambiguous evidence of the predominance of the tautomeric form 
containing an exocyclic C=N bond (i.e. an NH group in the ring) in CDCI3 solution. Since this 
is also valid for compound 76a, a change in the tautomeric equilibrium can not be detected in 
DMSO-fifc solution either. 
3. Synthesis and NMR study of norbornane- and norbornene-fused tetracyclic 
azetidinones1 
In view of the great medicinal importance of the penicillins and cephalosporins 
containing an azetidinone ring, increasing interest is attached to p-lactams.64 The methylene-
bridged, partly saturated 1,3- and 3,1-benzoxazines, prepared earlier in our laboratory,21 a-21b-23 
readily undergo cycloaddition reactions with chloroacetyl chloride to give fused-skeleton 
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azetidinones. This extension of rigid-skeleton norbornane-fused isomeric 1,3-oxazines is of 
stereochemical interest. These tetracyclic (3-lactams also seem promising from the point of 
view of biological activity, since the norbornane moiety is a component of many active 
compounds.26 
The subject of the present section is the conversion into tetracyclic azetidinones of the 
tricyclic fused-skeleton 1,3-oxazine derivatives that we had prepared earlier from the diexo-
3-aminobicyclo[2.2.1]hept-5-ene-2-methanol with imidates21a,21b-23 or by 1,4-cycloaddition 
from norbornene, norbornadiene and TV-hydroxymethylbenzamides (32a,b and 34b), and also 
the diendo- and d/exo-condensed 3,1-benzoxazines (80 and 81) from aminoalcohols 38a and 
39a.65 
The 1,3-dihydrooxazine compound formed with <fr'exo-norbornene (80) reacts by 
[2+2]-cycloaddition with ketenes prepared in situ from chloroacetyl chloride (82) or 
dichloroacetyl chloride (83) with triethylamine to give a product containing a mixture of two 
isomers (84a,b and 85a,b). An attempt was made to separate these compounds by column 
chromatography. Unfortunately, only the main products (84a and 85a) could be obtained in 
pure form, but their different solubility and chromatographic behaviour permitted isolation of 
the epimeric mixture, in which the minor products (84b and 85b) were enhanced. 
Thus, the structures could be established by abstracting the spectra of the main 
components from the NMR spectrum of the mixture by means of a computer 
compensation method. The results strongly suggested that the structures of the main 
components 84a and 85a were A, while those of the minor ones, 84b and 85b, were C and D, 
respectively (Scheme 16). 
Two diastereomers each of 86 and 87 (86a,b and 87a,b) were also isolated from the 
reaction mixture of the diendo derivatives; their structure elucidation has already been repor-
ted.23 On heating to 180 °C, 87a (mp 137-139 °C) is converted into the epimer 87b (mp 194-
195 °C), i.e. the configuration of the 5 S carbon atom changes to SR. Hence, the isomer 87b is 
the more stable. It was found that the structures of the main comformers 86a and 87a are A, 
while those of the minor ones, 86b and 87b, are D (Sceme 17). 
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CI 
82: ClCHzCOCl; 83: C12CHC0C1; 84a,b: X = H; 85a,b: X = CI 
Scheme 16 
Only one diastereomer each could be isolated from the mixtures of isomers 88-91 
starting from the 1,3-benzoxazines 32a,b, and of 92 and 93 from 34b (Scheme 18). The 
reaction of 32a with chloroacetyl chloride takes place in two directions: besides the 
azetidinone 88, a l,3-oxazino[2,36]-l,3-oxazine-4-one derivative 94 invilving fusion to 
norbornane and containing a nitrogen bridgehead could also be isolated, i.e. a derivative 
formed by reaction with two equivalents of chloroacetyl chloride. The synthesis of 
monocyclic dihydrooxazines from acyclic imines by reaction with acetyl chloride has been 
reported.66 The formation of diketene is assumed as the explanation of the reaction. Relatively 
simple bicyclic compounds of the aza orthoester-type have been prepared from dihydro-1,3-
oxazine by means of epoxide addition.6' 
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Ar: p-chlorophenyl 
D 
86b, 87b 
82: C1CH2C0C1; 83: Cl2CHCOCl; 86a,b: X = H; 87a,b: X = CI 
Scheme 17 
A 
86a, 87a 
NMR spectroscopic study 
A comparison of the spectral data reveals that in isomer 85a, isolated in the pure state, 
the configuration of C-2* is R (A), i.e. the phenyl substituent is in the endo position; the other 
component of the mixture, 85b, is the 2S exo-phenyl epimer (D). The main facts supporting 
this conclusion are as follows: 
a) The H-9 and H-9' signals for 85a show a considerable upfield shift (0.62 and 0.46 
ppm) as compared with those for epimer 85b. This is due to the anisotropic effect59 of the 
phenyl ring approaching H-9,9', causing shielding of the hydrogens situated "above" the plane 
of the ring. 
* In the spectroscopic sections, the numbering is uniform for all compounds investigated, in order to facilitate 
comparison of tire analogous data. 
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E 
88 R1: H, R2: H; Q = CH2CH2; 
89 R1: CI, R2: H; Q = CH2CH2; 
90R1:H,R2:C1; Q = CH2CH2; 
CI 
91R1:C1,R2:C1;Q = CH2CH2 
92 R1: H, R2: H; Q = CH=CH 
93 R1: H, R2: CI; Q = CH=CH 
Scheme 18 
82 ,83 
32a+ 82 ^ 
Et3N 
32a Ar: Ph; Q = CH2CH2 
32 b Ar:/>-chlorophenyl; Q = CH2CH2 
34b Ar: p-chlorophenyl; Q = CH=CH 
82: C1CH2C0C1; 83; Cl2CHCOCl 
b) The same effect can be observed for the H-8 signal; this signal is upfield-shifted by 
0.96 ppm as compared with that for 85b. 
c) A downfield shift by 0.76 ppm, as compared with 85b, is found for the H-8a signal; 
this shift is due to the deshielding effect of the coplanar carbonyl group.59 
This fact may be made the starting point in the determination of the C-10 con-
figuration in the analogous monochloro-substituted analogue 84a. As compared with the 
epimer 84b, the 2R configuration (endo phenyl group) can be inferred from the upfield shifts 
of the H-8,9,9' signals and the downfield shift of the H-8a signal, analogously to the case of 
85a. On the other hand, conformation A, analogous to that of the dichloro compound 85a, 
follows from the similar coupling constants /(4,4a) and J(4',4a), 7.8 and 8.6 Hz. In the event 
of a similar stereostructure, a chlorine in the trans position should give rise to a similar, 
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anomalous shift relationship (dHa>dHe) for the C-4 methylene hydrogens. As this is not 
observed, the cis arrangement of the phenyl and chlorine substituents relative to the 
azetidinone ring, and hence the R configuration at C-10, are apparent. The assignments of the 
signals of the axial and equatorial methylene hydrogens are given on the basis of the 
relationship 7(4',4a) > 7(4,4e), i.e. starting from the Karplus relation,37 7(a,a) > 7(a,e) > 7(e,e). 
The steric position determined in this way for the chlorine atom is explained by the 
circumstance that, due to the coplanarity of the C2-O3 and Cio-Cl/ra«i bonds, a strong electro-
static repulsion would appear between a trans chlorine atom and 0-3; the molecule can avoid 
this by assuming the R configuration at C-10. This phenomenon may be regarded as a special 
case of the anomeric effect68 69 that is well known in carbohydrate chemistry. 
Thus, it is readily understandable that conformation D is the preferred one for 85b; 
unambiguous evidence in support of this is provided by the significantly different, but 
relatively high values of the coupling constants 7(4,4a) = 6.6 Hz and 7(4',4a) = 12.2 Hz. The 
anomaly in the chemical shifts of the C-4 methylene hydrogens, observed in the case of 85a, 
is absent here; the signals of H-8 and H-9,91 are shifted downfield in comparison with those 
for 85a, due to the proximity of the carbonyl oxygen. On the other hand, the H-8a signal 
suffers an upfield shift, since H-8a is farther removed from the carbonyl group and, as it is 
above the plane of the phenyl ring, it is more shielded. 
Whereas the spectral data indicate the analogous conformation A for 84a and 85a, the 
spectral parameters of 84b suggest C as the preferred conformation. The most important 
evidence for this is given again by the similar and smaller coupling constants 7(4,4a) = 6.4 
and 7(4',4a) = 8 Hz, and also by the upfield shifts, i.e. slightly smaller for the signal of H-9, 
but higher for that of H-8 (0.55 and 1.05 ppm), than in the case of 84a (the corresponding 
differences in the pair 85a,b are 0.62 and 0.96 ppm). 
Differentiation of structures 86 and 87 is based on the changes in the chemical shifts 
of the olefinic protons as compared with 81. These shifts are decreased significantly for 86a 
and 87b. This can be explained by the anisotropy of the phenyl ring near the olefinic protons 
(~3 A) in structures 86a and 87b.23 
As regards the conformation, the values of the 4,4a and 4',4a couplings are the 
deciding factor. In conformation A the corresponding dihedral angles are ~35° and ~165°, 
while in B they are ~40° and ~90°, respectively. As the corresponding coupling constants for 
.... ~ Ss, 
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86a are 9.7 and 8.0 Hz, the preferred conformation is A. It should be noted that, for the same 
reason, conformation C should be taken into account for isomer 87a. Here H-7 and C=0, 
H-4'(a) and the endo chlorine atoms are near each other, but no sign of such a situation is 
observed in the spectrum. The magnitudes of the 4,4a and 4',4a couplings point to the fact 
that the anomalous chemical shift relationship 8H-4(e) < 8H-4'(a) for 81 is normalized here: 
5H-4(e) = 4.18 ppm and 8H-4'(a) = 3.32 ppm. Consequently, the H-4 signal for 86a is shifted 
downfield by 0.4 ppm, and the H-4' signal by 1 ppm in the opposite direction. This significant 
increase in the shielding of H-4' is also caused by the anisotropic effect of the aromatic ring, 
giving additional proof of conformation A. For conformation B, the anisotropic effect would 
appear in the signal of H-7, but not those of H-6 and H-4'. 
In the spectra of the two isolated dichloro compounds, the H-8a signal appears 
unchanged as a double doublet, as in the case of 81 and 86a. Consequently, the diendo 
annelation of the norbornene skeleton and the hetero ring is unaltered, as predictable. Thus, 
only structures 86b and 87b, differing in the annelation of the azetidinone ring, need be taken 
into consideration. From analogous spectral data for the monochloro derivative 86a, one 
isomer has an 86b-type structure and an -type conformation, while the other one has a struc-
ture 87b, similar to 87a, and conformation D. This is verified by the following facts: 
a) The shielding of H-6,7 in 87b is not increased, but decreased as compared with that 
for 81. The 0.4 ppm downfield shift of the H-7 signals is caused by the proximity of the 
carbonyl oxygen. 
b) Conformation D is proved by the values of the 4',4 and 4,4a couplings (9.3 and 6.2 
Hz for 87b and 7.3 and 7.2 Hz for 86b). 
c) H-8a in 87b is shielded by 0.7 and 0.6 ppm as compared with 86b and 86a having 
conformation D, where the anisotropy of the carbonyl group (which is much closer to H-8a) 
causes a downfield shift of the H-8a signal. Owing to the mutual positions of H-8a and the 
carbonyl group in conformation D of structure 87b, this effect is manifested as an opposite 
shift. 
d) The 4,4'-methylene hydrogens in 87b are shielded by the anisotropy of the four-
membered ring and that of the C-Cl bond. In the case of H-4', this does not compensate for 
the strong shielding effect of the phenyl ring that is operative in 86b. Consequently, H-4 is 
more shielded, while H-4' is deshielded as compared with 86b, but the H-4' signal for 87b is 
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more shielded than that for 81. Thus, in 87b, the normal relationship 8H-4(e) > 8H-4'(a) is 
again observed, but the difference ASH-4,4' is decreased. 
Structures of linearly fused azetidinones 88-94 
In view of the tabulated data3, structure E, i.e. the S configuration of C-2, can be 
assumed on the basis of the following arguments: 
a) H-4a is less shielded than in 84a,b and 85a,b (the H-4a signal is shifted from 1.71-1.98 
ppm into the region 2.30-2.45 ppm). 
b) The H-8a shifts cannot be compared directly, as the neighbouring nitrogen is replaced 
by oxygen. However, it is known59 that the presence and vicinity of an amide nitrogen, e.g. in 
cyclohexanes, causes a geminal proton deshielding that is about 0.7 ppm greater than in the 
case of an ether oxygen substituent; accordingly, the observed downfield shift of the H-8a 
signal can be rationalized only by structure E. 
c) A deciding argument in favour of configuration E is the very marked shift difference in 
the H-8a signals of the mono- and dichloro derivatives (0.36, 0.36 and 0.35 ppm for the pairs 
88-90, 89-91 and 92-93, respectively). The downfield shifts observed for the dichloro 
compounds are explained by the anisotropic effect of the chlorine atom.59 In the F isomers, 
both chlorine atoms are distant from H-8a, whereas in epimer E the chlorine trans to the 
phenyl ring is very close to H-8a. This is evidence of the cis arrangement of the chlorine and 
phenyl substituents on the azetidinone ring, and of the S configuration at C-10 in the 
monochloro compounds (88, 89 and 92). 
The IR spectrum of 94 does not display the characteristic azetidinone carbonyl band.10 
Instead, the amide-I band at 1672 cm"1, typical of simple amides, is observed, precluding the 
possibility of a P-lactam structure. The amide-III band, characteris-tic of A-substituted 8-
lactams,58 is found at 1415 cm'1. Besides the characteristic bands of the aromatic and aliphatic 
groups, the spectrum exhibits intense bands between 1300 and 945 cm"1, due to polar bonds 
such as C-O, C-Cl or C-N. 
The 'H NMR data afford evidence of the presence of the norbornane skeleton and the 
phenyl ring. The downfield shift of the H-4,4' signals can be accounted for by the anisotropy 
of the carbonyl group. The doublet split of the H-8a signal proves the unchanged diexo 
annelation of the norbornane and oxazine rings; the considerable upfield shift (~0.8 ppm) of 
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this doublet relative to that for the azetidinones 88-93, together with the somewhat smaller 
(~0.6 ppm) H-4a shift in the same direction, reflects the parallel, "endo" position of the 
phenyl ring (R configuration at C-2), since the anisotropic effect of the phenyl ring increases 
the shielding of H-4a,8a. In accord with this, H-91 {endo) is less shielded than in 88-93. The 
conformation of the oxazine ring is the same as in the azetidinones 88-93; this follows 
unequivocally from the coupling constants 7(4,4a) = 8 < 7(4',4a) = 11.5 Hz. In this 
conformation, if the configuration were C-2R {exo phenyl), increased shielding of H-91 would 
be observed, as a consequence of the proximity of the phenyl ring. The downfield shift of the 
H-5 signal by about 0.2 ppm is explained by the vicinity of the carbonyl group. Finally, the 
increased shielding of H-7 {endo) is also attributable to the anisotropy of the phenyl group. 
4. Preparation and steric structure of 3(2//)-pyridazinones, l,2-oxazine-6-ones and 
anthracene derivatives4 
This section describes the synthesis of several small-ring (cyclopropane- and cyclo-
butane-fused) analogues of some of the earlier heterocycles. An important feature of the 
compounds described here is that the synthons used are 2-aroyl-l-cycloalkanecarboxylic 
acids71'73 which yield fiised-skeleton heterocycles containing an aroyl group in the neighbour-
hood or on a bridgehead carbon atom in the fused heterocycle. The 2-aroylcyclohexane-
carboxylic acids and their cyclic derivatives have been reported to exert anorectic and 
hypotensive effects.74,75 
c/s-2-/>-Toluoylcyclopropane- (95) and -cyclobutanecarboxylic acids (96), cis- (97) 
and /m/w-2-/?-toluoylcyclohexanecarboxylic acids (98) and d/e«cfo-3-/?-toluoylbicyclo-
[2.2.1]heptane-2-carboxylic acid (99), prepared according to the literature71,73 or analogously 
from 7/'e//6fo-norbornane-2,3-dicarboxylic anhydride and toluene by the Friedel-Crafts 
reaction, were cyclized with hydrazine hydrate and phenylhydrazine to the cyclopropane-, 
cyclobutane- and cyclohexane-c/s-fused 4,5-dihydro-3(2//)-pyridazinones (100a, 101a and 
102a), the corresponding trans derivative (103a) and their 2-phenyl derivatives (100b-103b) 
(Scheme 19). 
For pharmacological aims, the analogous norbornane-7/ewifo-condensed pyridazin-
3(2//)-ones (1104a,b) were also prepared. As potential drugs, the non-condensed or 
differently substituted derivatives of the 4,5-dihydropyridazinones have already been 
synthesized.73,75,76 
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(CH2)n 
COOH 
H-,NNHR (CH2)n 
Ar 
100a,b, 101a,b 
102a,b, 103a,b 
H,NOH.HCl —*—— (CH 2 ) n 
COOH 
cis: 95-97, 100-102, 105, 106; trans: 98, 103, 107; a: R = H; b: R = Ph; Ar = p-tolyl 
n = 1 (95, 100, 105); n= 2 (96, 101); n= 4 (97, 98, 102, 106, 107) 
Scheme 19 
With hydroxylamine hydrochloride, synthons 95 and 97-99 yielded the cyclopropane-
cis- (105), cyclohexane-c/s- (106) and trans- (107), and norbornane-i//<?//t/o-condensed (108) 
4,5-dihydro-1,2-6//-oxazine-6-ones. 
As the aroylcyclohexanecarboxylic acids also appeared to be suitable for the synthesis 
of partially saturated anthracene derivatives, the synthons 97-99 were reduced by the Wolff-
Kishner method. The product obtained from both 97 and 98 was the iram--2-/Molylmethyl-
cyclohexanecarboxylic acid77'79 (109a), while the reduction of 99 led to the corresponding 
norbornane derivative 117 (Scheme 20). 
The isomerization of the cis compound 97 presumably took place during the vigorous 
hydrazine reduction (200 °C, KOH). For dihydrouracils, cis-trans inversion on the action of 
acids, bases or heating is known.80 In the present case, the isomerization 97-»109a was 
proved by further reactions. Reduction and cyclization of the cis 97 and the trans synthon 98 
gave the same trans compound 111a. The configuration of the fixed methylene-bridged 
diendo analogue 99 was not changed by the reduction. 
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NaBH 4 > 
97, 98 110a,b, l l l a , b 
112,113 ° 
toluene 
COOH 
H2NNH2^ 
o 200 °C 
LAH 
A1C1, 110b 
O 
114,115 
L.SOCL2 
2. A1C13 
cis. 97, 110, 112, 114; trans: 98, 109, 111, 113, 115; 
Ar = /t-tolyi a: R1 = Me, R2 = H; b: R1 = H, R2 = Me 
Scheme 20 
From c/'s-4-cyclohexene-l,2- and i//'i?/it/o-5-norbornene-2,3-dicarboxylic anhydride, 
the preparation of the oxocarboxylic acids of types 97-99 under similar conditions was 
unsuccessful because of the saturation of the double bond in the Friedel-Crafts reaction. Thus, 
for the synthesis of the c/s-hexahydroanthrone, the c/'s-hexahydrophthalic anhydride 112 was 
reduced with NaBFLt to the c/'s-lactone 114, which was then reacted with toluene in the 
presence of a large excess of AICI3. This reaction directly gave c/'s-6-methyl-l,2,3,4,4a,9a-
hexahydroanthrone (110b) instead of the 7-methyl derivative (110a). 
Starting from ira/?s-hexahydrophthalic anhydride (113), ira/w-6-methylanthrone 111b 
was formed in the same way. Thus, acylation, Wolff-Kishner reduction and cyclization of 
the trans anhydride 113 yields the rra«s-7-methylhexahydroanthrone (111a), whereas the 
route starting with reduction of 113, followed by simultaneous Friedel-Crafts acylation and 
cyclization, furnishes the regioisomeric 6-methylhexahydroanthrone 111b. 
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On the cyclization of 117 in the presence of AICI3, the tetracyclic 1,4-methylene-
bridged hexahydroanthrone 118 containing the norbornane diendo-Rised structural moiety 
was formed. Reduction of 6-methyl-cw-hexahydroanthrone (110b) with LAH/A1C13 gave the 
corresponding c/'s-octahydroanthracene 116. The syntheses of cis- (110a) and trans-octa-
hydroanthracen-9-one (111a) were described earlier77*79 and the preparation of 
6-methyl-l,2,3,4,4a,9,9a,10-octahydroanthracene (116) by reduction of 110a is also known.77 
Mathur and Bhargava applied the WolfF-Kishner method to reduce 110, obtained from 97 by 
reduction with hydrazine and subsequent cyclization, and reported the isolation of crystals of 
116 with mp 126 °C in very good yield (90.3%).77 
We repeated their work with 110b, but the reduction and cyclization gave a colourless 
liquid (yield 64%). *H NMR indicated that the product contained some starting 110b (11%) 
besides 116. Reduction of 110b with LAH proved to be more convenient; for isolation, a 
HPLC method was applied, which resulted in 116 (35% of the distilled product), mp 
77-80 °C. 
For 110b, the cis annelation of the cyclohexane and cyclohexenone rings is proved by 
the broad NMR signal (-15 Hz) of the annelated methine hydrogen vicinal to the carbonyl 
group. It also shows that the carbonyl group is axial and that the methylene group in the 
cyclohexenone ring is equatorial, which is in accordance with the higher spatial requirements 
of the methylene group as compared with those of the carbonyl group.81 The corresponding 
signal width of the trans analogues 111a,b is -30 Hz. For 111a,b, this signal appears 0.5 ppm 
upfield of that measured for 110b, which is a consequence of the equatorial-» axial 
change.13,59 Similarly, the 15 Hz signal width and the downfield shift of the signal of the 
hydrogen vicinal to the carbonyl group as compared with the signals for the trans isomers 
103a,b suggest a conformer containing an axial carbonyl group for the m-annelated 
compounds 102a, b. 
This also holds for the former of the cis-trans pair 106-107: the signal of the methine 
hydrogen vicinal to the carbonyl group is sharper (signal width - 8 Hz; -30 Hz for 106) and 
downfield shifted (by 0.63 ppm). Thus, the carbonyl group is axial to the cyclohexane chair 
ring in the preferred conformation. 
Further proof of the cis-trans structures is that the sum of the cyclohexane carbon 
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shifts is 8.7 ppm smaller for cis 110b than for trans 111b.59 For 111a and 111b, the trans-
annelated structure follows from the same magnitude of the carbon shifts. 
For 100a,b and 105, the significantly different shieldings and signal splittings of the 
two cyclopropane methylene hydrogens are noteworthy. The anisotropic effect of the hetero 
ring causes a strong upfield shift of the signal of the methylene hydrogen which is situated 
above the ring and trans to the vicinal hydrogens. The assignment based on the higher cis 
vicinal coupling59 is beyond any doubt. For 104a,b and 108, the double doublet pattern of the 
signal of the heterocyclic annelated hydrogens23 unambiguously proves the diendo annelation 
of the hetero ring and the norbornane moiety. 
For 111b, the 6 position of the methyl group was proved by NOE measurements. 
5. Synthesis and structure of methanobenzocyclooctene derivatives5 
As starting compound, C7's-4-cyclohexene-l,2-dicarboxylic anhydride was applied;82 
through the addition of benzene to the double bond, this furnished 4i-phenylcyclohexane-
lr,2c-dicarboxylic acid (119a) with a phenyl group equatorial83 to the neighbouring carboxy 
group. It was thought that the 4-phenyl substituent on cyclohexane-l,2-dicarboxylic acid 
might provide a good opportunity to construct highly condensed systems by intramolecular 
acylation of the phenyl substituent with the 2-carboxy group. These systems containing two 
functional groups are suitable for the preparation of heterocycles and they provide good 
starting molecules for the production of new pharmacologically active derivatives as target 
compounds. 
When heated in concentrated H2S04, fra/M-4-phenylcyclohexane-c/s-l,2-dicarboxylic 
acid 119a or in 80% H2S04> the anhydride 120 yielded 10-oxo-5,6,7,8,9,10-hexahydro-5,9-
methanobenzocyclooctene-8-carboxylic acid (122a, yield 13% and 15%, respectively) by 
intramolecular cyclization (Scheme 21). 
Similar cyclization via AlCb-catalysed intramolecular Friedel-Crafts acylation 
provides only a moderate yield (14-21%),84 in spite of the absence of strain in the bicyclo-
nonanone ring system.85 Other preparations are also known,86-87 e.g. from benzylcyclo-
hexanone with methyllithium,88 from unsaturated enol silyl esters with eerie ammonium 
nitrate,89,90 from alkenes by methylsulphite cyclization91 and by carbocationic cyclization of 
unsaturated bromoimines.92 
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Scheme 21 
To improve the yield of 122a, we started from dimethyl 4-/ra/w-phenylcyclohexane-
cA-l^-dicarboxylate (121a). Cyclization with polyphosphoric acid (PPA) at elevated 
temperature yielded a mixture of the isomeric esters 123a and 123b in a ratio of 1:5. In 
contrast, the cyclization of dimethyl 4/-phenylcyclohexane-lr,2/-dicarboxylate (121b) gave 
the esters 123a and 123b in a ratio of 5:4 (the yield of 123a,b was 54%). Consequently, as a 
result of the transformation 121b-»123a,b with PPA, the 30% yield of 123a isolated from the 
mixture 123a,b by column chromatography proved to be sufficient to permit further reactions. 
We presume that in the cyclization, the 2-carboxy groups, which are axial in the ground state, 
ft 
V, 
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come close to the phenyl group by ring inversion and 121a and 121b partly isomerize to form 
the products 123a,b. After separation of the isomers, the structures were established by NMR 
spectroscopy. The esters 123a,b were hydrolysed and the acids 124a,b were characterized by 
NMR and for 122a also by X-ray analysis (Figure 1). The oxo group of 123a was reduced by 
the Wolff-Kishner method to afford a mixture of cis- and /ra«s-5,6,7,8,9,10-hexahydro-5,8-
methanobenzocyclooctene-8-carboxylic acids (124a,b). With hydrazine, the oxocarboxylic 
acid 122a was cyclized to the tetracyclic methanobenzocycloocta[9,8-c,d]pyridazinone (125). 
Figure 1 
X-ray structure of compound 122a 
In consequence of the strong steric hindrance between the a-axial COOR group and 
the skeleton, no boat conformation of ring C is possible (Scheme 21, 122a, /'). For a chair 
conformation and a cis configuration (Scheme 21, 122a, //), the axial H-8 is in a trans-diaxial 
position with one of the neighbouring H-7 atoms, and the correspondingly large coupling3" 
appears in the *H NMR spectra of one each of the acid and ester isomers; for 122a and 123a, 
the H-8 signal is a triplet of doublets split by 13.3, 4.1 and 4.1 Hz. 
As the H-8 multiplet of 122b and 123b does not exhibit a large splitting, the chair 
conformation of ring C is also preferred for the trans isomers; hence, the COOR group is 
axial and the equatorial H-8 has no diaxial (i.e. large vicinal) coupling (Scheme 21). The 
spectral data on the reduced products 124a,b confirm the above structures. For 
C-7 and C-l 1, the chemical shifts hardly differ from those measured for 122a,b and 123a,b. 
34 
For the isomeric pairs 122a,b and 123a,b, the shifts of C-6, C-8 and C - l l differ significantly 
due to the strong steric hindrance between the axial 8-COOR group and H-6ax and H-l lax in 
the trans isomers. For 124a,b, only the shift difference for C-6 and C- l l is significant; that 
for C-8 is significantly smaller (A5C-8 = 1.3 ppm). The explanation lies in the strong steric 
hindrance between the endo 10-methylene hydrogen and the equatorial 8-COOH group of the 
cis isomer, and therefore the C-8 line is also shifted upfield for the cis isomer. 
To summarize, the intramolecular cyclization of 121a with PPA yielded the isomers 
123a and 123b, which differ in the configuration of C-8; for 123a, H-5, H-8 and H-9 lie on 
the same side of ring C, while in 123b, H-5 and H-9 are on the same side and opposite to the 
hydrogen geminal to the carboxy group. On reduction of the acid 122a, the isomers 124a (all-
cis) and 124b (5/H,8/H,9cH) are formed in a ratio of 1:2; the epimerization probably takes 
place via enolization of the 8-CO (carboxy) group. 
123a can be prepared from the trans ester 121b more advantageously than from the cis 
ester 121a, and its 30% yield allows its use as a starting molecule for the synthesis of highly 
condensed systems. Hence, intermolecular acylation with PPA at an elevated temperature is 
an appropriate method of obtaining the methanobenzocyclooctene system. 
6. Preparation and structure of partially saturated isoindolo[1,2-6]- and -[2,l-a]quina-
zolines6 
2-Carboxybenzaldehyde 126 reacts with cyclic diamines in which one of the functi-
onal groups is bound to a cyclohexane/ene ring directly, and the other indirectly through a 
methylene group. When boiled together in toluene, 2-carboxybenzaldehyde 126 and cis-2-
amino-l-cyclohexylmethylamine 127a yielded three products: the linearly condensed 128 and 
129 or the angularly-fused 130 (Scheme 22), which were separated by HPLC. After isolation 
and crystallization, the structures of tetracycles 128-130 were established by NMR 
spectroscopy. The linearly-fused products 128 and 129 proved to be isoindoloquinazolinones 
containing an aromatic ring A, two condensed hetero rings and one terminal cyclohexane unit. 
Similar structural isomers have been prepared in the reaction of P-aroylpropionic acid with 
127a.93 
In the reaction of 126 with fraws-2-amino-l-cyclohexylmethylamine 127b, only one 
product (131) was isolated. Likewise, in the reactions of 126 with cis- or /ram-2-amino-
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cyclohex-4-enyl-l-methylamine (127c and 127d), 132 and 133 were obtained. Similarly, to 
128 and 129, these compounds are linearly condensed isoindoloquinazolinones. The spectral 
data indicate that the formation of these tetracyclic ring systems is straightforward.6 
The theoretically equally possible linearly or angularly condensed ring systems can be 
differentiated on the basis of the chemical shifts of the NC// and NC//2 hydrogens. Due to the 
anisotropic effect of the carbonyl,59 the former and one of the latter give significantly 
downfield shifted signals: 4.5 ppm (130) instead of 2.6-3.4 ppm (128, 129 and 131-133), and 
3.37 (130) instead of 4.15-4.43 ppm (128, 129 and 131-133). Consequently, 128, 129 and 
131-133 contain the methylene group vicinal to the amide nitrogen, while in 130 the CH 
group is bound to this nitrogen atom. Hence, all these new compounds have linearly 
condensed skeletons, with the exception of 130, which alone has an angular structure. 
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The cis- or ¿ra/75-condensed cyclohexane rings differ in the carbon shifts: due to the 
field effect (steric compression shift63), the sum of the carbon shifts (ISC) is significantly 
smaller for the cis compounds. ISC is 184.5 ppm (128 and 130) or 188.8 ppm (129) for the 
c/5-annelated cyclohexanes, and 217.9 ppm for their trans counterpart 131 (AI8C » 32.0 
ppm). Similarly, AI8C is 22.6 ppm for the cyclohexene cis-trans pair 132 and 133, and cis 
annelation for 128-130 and 132 is unquestionable. 
A further problem is to determine the relative positions of the isoindolone NC//N 
hydrogen and the annelational hydrogens of the partially or wholly saturated quinazoline ring. 
This was established by means ofDNOE measurements.59,94 
On saturation of the isoindolone H-5a, responses from H-4a, H-12ax and H-6 were 
observed for 128 and 131-133, which proves the steric proximity of the latter atoms to 
H-5a. 
For 129, the cis annelation of the cyclohexane and the vicinity of the methylene group 
to the amide-N was proved above. In the knowledge of the structure of the diastereomer 128, 
which contains a cA-annelated cyclohexane ring, the only possible structure for 129 that 
remains is that in which the annelational hydrogens and H-5a are in the trans arrangement. In 
comparison with 128, the significant field effects on C-5a (5.2 ppm) and (5.8 ppm), due to the 
steric interaction with the 4-methylene group in the 1,3-diaxial position, are proof of this 
structure. The corresponding field effects on 2-CH2 and 4-CH2 are 4.4 and 5.0 ppm. 
Consequently, 129 has the relative configuration 4a/?,5aS',12a/?. The above results support our 
previous findings:71,93,95 in similar cyclizations, the cis or trans cyclic 1,3-aminoalcohols or 
1,3-diamines always react with retention of the configuration. 
7. The first preparation of a heterotricycle, [l,3]oxazino[2,3-a]isoindole-2,6-dione, by a 
retro Diels-Alder method7 
diendo- and 7/'exo-3-Aminobicyclo[2.2.1]hept-5-ene-2-carboxylic acids (45 and 47)38,21a 
were recently used to prepare known and previously unknown heteromonocycles25 and 
bicyclic derivatives in retro Diels-Alder (RDA) reactions.96,97 The principle of these procedu-
res is the synthesis of the partially saturated parent heterocycles on cyclopentadiene, which is 
removed from the condensed-skeleton molecules in the final reaction step, resulting in the 
target compound by introduction of a new double bond. The importance of the RDA reaction 
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was recently highlighted by its application for the preparation of an enantiomerically pure 
compound98 and its study in aqueous solution.99,100 The present section describes an extension 
of the scope of this new retrodiene reaction, i.e. the application of 2-carboxybenzaldehyde 
(126) for the preparation of fused-skeleton heterotricycles from norbornene amino acids 45 
and 47. 
The reactions of 2-carboxybenzaldehyde (126) with diendo- or J/exo-3-aminobicy-
clo[2.2.1]hexane-2-carboxylic acids (44 and 134) or diendo- or c7/'exo-3-aminobicyclo-
[2.2. l]hex-5-ene-2-carboxylic acids (45 and 47) gave 1,4-methanohexahydro- (135a,c) and 
tetrahydroisoindolo[2,l-a][3,l]benzoxazine-6,12-diones (135b,d) in moderate yields (45-
54%, Scheme 23). 
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Scheme 23 
In all these compounds, the diexo- or ¿//eHc/o-norbornene annelational hydrogens and 
the 1,3-oxazinoisoindoledione NC/ /0 hydrogen are in the cis arrangement. Similarly as ob-
served earlier for related norbornene-fiised 1,3-heterocycles, 135b,d undergo retrodiene 
decomposition when heated to their melting points. In these reactions, cyclopentadiene splits 
off and 2//,6//-l,3-oxazino[2,3-a]isoindole-2,6-dione (136) is formed, which can be isolated 
in 38-42% yield after a simple purification by column chromatography. 
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Cycloreversion proceeds readily in the retrodiene decomposition, i.e. a new double 
bond is formed between the two carbons of the target molecule if an oxo- or thioxosubstituted 
heteroaromatic or quasi-heteroaromatic system is formed, e.g. pyrimidinone, pyrimidinedione, 
thioxopyrimidinone or l,3-oxazine-6-one.25 The present case is the first example of the 
formation of a fused tricyclic hetero compound containing two fused partially 
saturated hetero rings and one aromatic ring in a RDA reaction. The overall structure, but 
especially the fused l,3-oxazine-6-one terminal ring in 136, is very similar to the heteromono-
cycle 2-aryl-l,3-oxazine-6-ones which were prepared in an analogous way," with the 
difference that 136 contains no C=N bond between the aryl-substituted carbon and the 
nitrogen of the six-membered hetero ring. However, in the structure of 136, a fused aromatic 
ring is attached to the sp3 carbon situated between the two hetero atoms, and a benzoyl 
carbonyl is attached to the bridgehead nitrogen. This structural pattern lends a quasi-aromatic 
character to the l,3-oxazine-6-one system produced by the splitting-off of cyclopentadiene, 
although it is obvious that the formation of this ring system is less favourable than that of the 
related heteroaromatic monocycles, for in these tricycles the second double bond in the six-
membered hetero ring is missing. The energy difference between the heteroaromatic 
monocyclic and quasi-heteroaromatic tricyclic systems is reflected by the much higher 
temperature necessary for the formation of 136. 
The present results encourage us to extend the scope of the RDA method in the 
direction of more complicated hetero compounds in which the electrons required for terminal 
hetero ring formation are supplied by heteroatoms, i.e. the preparation of new polycyclic 
hetero compounds can be anticipated. Analogous condensed-skeleton heterocyclic compounds 
similar to the earlier synthesized heteromonocycles may be obtained in RDA reactions from 
molecules containing electron-rich structural moieties which promote the formation of the 
new double bond in the product and substitute the second double bond formally required for 
the aromaticity of the (terminal) hetero ring of the product. 
The above method affords an easy synthesis of the previously unknown tricyclic 
system 136 and illustrates the general scope and importance of formation of a partially 
unsaturated or aromatic hetero compound via the RDA technique, by building up a 
heterocyclic molecule on the norbornene derivative prepared from cyclopentadiene and 
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splitting off the cyclopentadiene by heating in the final reaction step. This method does not 
require the flash vacuum pyrolysis applied in traditional RDA reactions.101 
The structures of the new compounds 135a-d and 136 follow straightforwardly from 
the spectral data.7 For 135a-d, the diexo or diendo annelation of the norbornane/ene unit to the 
oxazinone ring can be determined via the multiplicity of the annelated hydrogens in positions 
4a and 12a.23 102 In the diexo compounds 135a,b, as a consequence of the dihedral 
angles, which are ~90°, the H-l/H-12a and H-4/H-4a interactions are not significant 
(according to the Karplus relation37), and hence the H-4a and H-12a signals are doublets 
corresponding to the mutual interactions of these hydrogens, while for the diendo 135c,d 
these signals are double doublets (here the above dihedral angles are ~30°). The relative 
configuration of C-lOb (between the N and 0 ) must also be determined. This is possible by 
means of NOE measurements.94,59 The results of these experiments show the all-cis 
arrangements for H-4a, H-lOb and H-12a in all pentacyclic compounds. 
8. Comparative bioanalytical study of [3H]deramciclane in dog plasma, using gas 
chromatography - nitrogen-selective detection (GC-NPD), a new GC-radiochemical 
detection (GC-RD) technique and liquid scintillation8 
Deramciclane fiimarate (l/?,25,4/?)-(-)-AT,i\Adimethyl-2[(l,7,7-trimethyl-2-phenylbi-
cyclo(2.2.l)hept-2-yl)oxy]ethaneamine-2-(E) butenedioate (1:1) (EGIS-3886, Scheme 24) is a 
new non-benzodiazepine-type anxiolytic compound"03 106 developed by EGIS Pharmaceuticals 
Co. For the determination of deramciclane in plasma samples collected in pharmacokinetic 
studies performed in different species, several different gas chromatography methods have 
been elaborated. In pharmacokinetic studies on rats, dogs and rabbits, different highly 
sensitive nitrogen-selective and mass spectrometry detection methods had to be applied 
because of the low doses and the "first-pass" metabolism, which varied in intensity depending 
on the species.107,108 With these methods, the parent compound and its N-demethyl metabolite 
(EGIS-7056) were selectively determined in plasma samples. In in vitro and in vivo studies of 
the metabolism of deramciclane, thin-layer chromatography with digital autoradiographic 
detection109 (TLC-DAR), TLC-DAR-FAB-MS-MS110 coupling and HPLC separation followed 
by radiochemical detection (HPLC-RD) were applied. In pharmacokinetic studies, liquid 
scintillation counting' (LSC) is frequently used for the determination of drug molecules 
labelled with different radioisotopes in biological matrices.111"113 This method allows 
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determination of the total radioactivity of the sample without separation of the parent 
compound and its metabolite(s). 
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From among the techniques possible in pharmacokinetic and metabolite kinetic 
studies, radio-gas chromatography (developed in the 1980s) is used relatively infre-
quently.114115 The HPLC-RD technique offers the advantage of the possibility of metabolite 
isolation for structure identification at a micropreparative level; the advantage of GC-RD is 
the high sensitivity. 
Comparative bioanalytical investigations were performed by the analysis of plasma 
samples from beagle dogs treated with [3H]deramciclane. Total radioactivity was determined 
by LSC, while the plasma levels of [3H]deramciclane and its A-demethyl metabolite were 
determined by capillary gas chromatography, with the applyication of two different detection 
methods. The previously elaborated GC-NPD bioanalytical method was compared with the 
new and optimized coupled technique of GC-RD, which allowed selective determination of 
the radioactive components of the sample. Various pharmacokinetic parameters calculated 
from the plasma concentration-time curves of the parent compound and its metabolite, 
measured by different analytical methods, were compared with those obtained by determi-
nation of the total radioactivity levels. These results demonstrated the usefulness of this 
method for the analysis of biological samples. 
\ 
.(CH)2(COOH)2 
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In vivo study phase 
[3H]Deramciclane and unlabelled deramciclane were weighed separately, and then 
mixed in a ratio of 1:14 to obtain an appropriate radioactive concentration according to the 
desired limit of detection (approximately 500 pg equiv/ml plasma). The homogeneity and 
specific activity of the mixture were checked by LSC. The specific activity of the homogenate 
was 4.80 MBq/mg (287 831 dpm/mg). The radioactive test material was formulated in a hard 
gelatine capsule. After 7 days of acclimatization and 12 h of fasting, a 1-year-old male beagle 
dog weighing 9.9 kg was treated with a single 10 mg/kg oral dose of the above [3H]deram-
ciclane formulation. 
Blood samples for the pharmacokinetic experiments were taken from the brachial vein 
with a Vasocan cannula containing \% heparin in physiological saline solution, or wia a 
venipuncture: 9 ml of blood was drawn into a glass tube containing 1 ml of anticoagulant 
(EDTA) solution (the sampling times are presented in Figures 3 and 4). Blood samples were 
centrifiiged at 2000 g for 10 min, and the plasma was separated and stored in a deep-freezer at 
-20 °C until processing. 
Processing of plasma samples 
Dog plasma samples stored at -20 °C were allowed to thaw at room temperature and 
then extracted on a previously washed and activated LiChrolut 200 mg RP-18 solid-phase 
extraction column, using a previously developed method.107 Substances to be determined were 
eluted with 1 ml of 1% (v/v) acetic acid in methanol into an Eppendorf tube. The eluate was 
next evaporated to dryness in a stream of nitrogen on a lukewarm waterbath. The residue was 
then dissolved in 50 pi of 2-propanol and transferred into a disposable microvial. Two pi was 
injected into the gas chromatograph with an autosampler (GC-NPD) or manually 
(GC-RD). 
Determination of [3H]deramciclane and A-demethyl-[3H]deramciclane concentration of 
plasma samples 
Quantitative determination of [3H]deramciclane and its main metabolite was perfor-
med on the basis of the peak area values recorded by the GC-RD instrument. The equation of 
the external standard calibration was Q = l . l l l(y-b)/a, where Q is the ng equiv/ml value of 
[3H]deramciclane, a and b are the parameters of the calibration line, y is the peak area and 
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1.111 is a correction factor for the dilution caused by the anticoagulant. In the lack of a 
reference standard of TV-demethyl-[3H]deramciclane, its concentration in plasma samples was 
also calculated with the above equation. In each run, the suitability of the GC-RD system was 
checked with an extracted plasma sample taken 4 h after treatment (Figure 2). 
Cu 
u 
C/5 
c 3 O 
U 
c^ s 
1 
à 
A 
. i . 
K 
f B 
I t . M 
Time (min) 
Figure 2. Radio-gas chromatogram of a dog plasma extract; system suitability test. Sampling 
4 h after the administration of 10 mg/kg [3H]deramciclane. A: [3H]deramciclane, 
B: A-demethyl-[3H]deramciclane. 
The new radio-gas chromatography method 
A new, highly sensitive, simple GC-RD method was developed and validated for the 
selective determination of [3H]deramciclane and /V-demethyl-[3H]deramciclane. The two 
compounds were separated on a fused silica capillary column under optimized, programmed 
temperature and pressure conditions. Tritium-labelled molecules were subjected to reduction 
at 750 °C in the presence of a platinum catalyst under a stream of hydrogen to yield 
radioactive methane gas that could be measured with a proportional counter. After a partial 
validation of the bioanalytical method, the GC-RD system was used to determine the 
[3H]deramciclane concentration in biological samples. 
The method was validated according to the reported consensus."6 The linearity of the 
calibration curve was investigated in the concentration range 13.71-1000 ng/ml, using spiked 
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plasma samples. The calibration equation was calculated from the peak area values of 
[3H]deramciclane with 1/y1 weighting, which is common in bioanalytical practice. The 
8.9-fold difference between the specific activity of the [3H]deramciclane reference standard 
and that of the tritiated deramciclane used for the animal treatment was taken into 
consideration in calculation of the calibration equation. Three calibrators were measured at 
each concentration level in the wide calibration range in order to determine the linearity, 
accuracy and precision of the determination of [3H]deramciclane. The linearity, precision and 
accuracy were characterized by the coefficient of variation, the RSD and the deviation from 
the nominal concentration, respectively. The system suitability of the radio-gas 
chromatograph was tested at a concentration of 200 ng/ml, after five parallel injections from a 
spiked and extracted plasma sample. 
The radio-chromatogram (Figure 2) of the extract of dog plasma sample taken 4 h after 
treatment with a single 10 mg/kg oral dose of [3H]deramciclane revealed the well-separated, 
symmetrical peaks of the parent compound and its metabolite. The calibration curve exhibited 
very good linearity for [3H]deramciclane in the concentration range 13.7-1000 ngequiv/ml 
(r = 0.999). According to the validation results, the lower limit of the quantitation of the 
GC-RD method was 13.7 ng equiv/ml. The limit of detection was 1 ng equiv/ml; in spite of 
the low specific activity, this was comparable to the sensitivity of the GC-NPD method.107 
The inter-day precision and accuracy values for [3H]deramciclane satisfied the 
acceptance criteria specified for non-radioactive methods. Despite the absence of an 
appropriate 3H-labelled internal standard, the linearity and reproducibility were acceptable 
with external standard calibration. The accuracy and precision were on the average 2.35 and 
7.19%, respectively. The RSD value obtained during the system suitability test of the GC-RD 
system was 1.78%. 
Pharmacokinetic and statistical analysis 
The pharmacokinetic parameters were determined from the plasma concentration-time 
data by using Siphar/Win validated pharmacokinetic software; the statistical evaluation was 
performed with Statistica for Windows ver. 4.5 software. With the above GC-RD method, 
plasma levels of 3H-labelled deramciclane and its W-demethyl metabolite were measured in 
dog (Figure 3) after the administration of a single oral dose of 10 mg/kg. [3H]Deramciclane 
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displayed relatively fast absorption, and plasma levels could be detected up to 36 h. The 
pharmacokinetic parameters of A-demethyl-[3H]deramciclane were in good agreement with 
the pharmacokinetic parameters of the same metabolite obtained with the GC-NPD method. 
The pharmacokinetic curve and the most important pharmacokinetic parameters of 
[3H]deramciclane were compared with those obtained after previous GC-NPD measurements, 
and with the non-selective total radioactivity (LSC) data (Table 1, Figure 4). 
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Figure 3. Pharmacokinetic curves of [3H]deramciclane and A-demethyl-[3H]deramciclane in 
dog, determined by GC-RD after the administration of a 10 mg/kg oral dose of 
[3H]deramciclane. 
The pharmacokinetic curves and the calculated pharmacokinetic parameters obtained with the 
two different, independent detection techniques were closely similar. 
The comparison of these results and those obtained by measurement of the total 
radioactivity in the plasma (LSC) showed that the low plasma concentration ( A U C o - o o ) of the 
parent compound was indicative of a very fast and intensive first-pass metabolism Moreover, 
the elimination of radioactivity (additional metabolites) (tp./, = 97.3 h) was very slow as com-
pared with those of the parent compound and the A-demethyl metabolite (7.6 h). It could be 
seen that further metabolites are formed which should be identified for the safety 
pharmacology. 
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Figure 4. Comparison of the pharmacokinetic curves obtained in dog with various 
bioanalytical methods 
Table 1. 
Comparison of the pharmacokinetic parameters of deramciclane calculated from plasma 
concentration-time data obtained with different bioanalytical methods, after a single oral 
administration of 10 mg/kg [3H]deramciclane in dog. 
Measured moiety Method AUCo-cc C m a x tmax MRT tPv, 
(ng*h/ml) (ng/ml) (h) (h) (h) 
Deramciclane GD-NPD 12861,3 1018,3 2,5 9,9 7,68 
[3H]Deramciclane GC-RD 10252,8 967,8 2,9 11,5 7,57 
Total radioactivity LSC 269000,0 3480,0 2,9 138,0 97,30 
Summary 
Saturated and partly saturated norbornane and norbornene-condensed 1,3-heterocycles 
were synthesized for pharmacological purposes. In the synthetic work, the resulting isomers 
were separated by chromatographic methods, which resulted in stereohomogeneous cis and 
trans, exo and endo products. 
Thus, by the cyclization of norbornane and norbornene aminoalcohols with imidates, 7 
saturated and unsaturated norbornane-fiised 1,3-oxazines were prepared and transformed by 
[2+2] ketene cycloaddition to tetracyclic azetidinones. The isomeric products were separated 
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and the structures of the adducts were established by means of IR, 'H and ,3C NMR 
spectroscopy. With isothiocyanates, the unsaturated aminoalcohols and the //-methyl and N-
benzyl derivatives were converted into thioureas. The cyclization of the latter gave diendo-
and 7/'exo-2-phenylimino-5,8-methano-3,l-benzothiazines and tricyclic 1,3-oxazinethiones as 
side-products. Additionally, isothiuronium salts were prepared from the thioureas and 
cyclizedto 1,3-oxazines. 
The reactions of 2-aroylcyclopropane and -cyclobutanecarboxylic acids and the 
corresponding bicyclo[2.2.1]heptane carboxyclic acid with hydrazines yielded cycloalkane-
condensed 3(//)-pyridazinones and the norbornane diendo-fused derivatives. With 
hydroxylamine, condensed l,2-oxazine-6-ones were prepared. Transformation of the aroyl 
cycloalkane-carboxylic acids led to stereoisomers isobenzofuranones. The partly saturated 
anthrones and the 2-methyloctahydroanthracene derivatives were also prepared from them. By 
intramolecular cyclization of 4/-phenylcyclohexane-lr,2c-dicarboxylic acid or its ester in 
concentrated H2SO4, methanocyclooctene isomers were obtained; the oxo group was reduced, 
to result in cis and trans methylene-bridged benzocyclooctenes. With hydrazine, tetracyclic 
pyridazinone derivatives were obtained. The reactions of 2-carboxybenzaldehyde with 
aminocyclohexenylmethylamines yielded isomeric isoindoloquinazolinones; two linearly cis-
fused and one angularly /raws-fused tetracycles were formed. 
Hexahydro- and tetrahydroisoindolobenzoxazinediones were prepared by the reactions 
of 2-carboxybenzaldehyde with norbornane/enecarbocyclic acids. When heated, the norbor-
nene derivatives underwent retrodiene decomposition by splitting off cyclopentadiene to give 
the l,3-oxazino[2,3-a]isoindole-2,6-dione. This is the first example of the preparation of a 
condensed heterotricyclic compound in a retro Diels-Alder reaction. The structures of the 
compounds were established by means of IR, 'H and l3C NMR methods. 
A new GC-RD bioanalytical method was used for determination of the plasma level of 
[3H]deramciclane and its metabolite in dog, after the administration of a single 10 mg/kg oral 
dose. The pharmacokinetic parameters calculated were compared with those obtained by GC-
NPD and total radioactivity (LSC) methods. Comparison of these results demonstrated that 
deramciclane metabolizes intensively. Moreover, the biological half-lives (tp>/,) of the 
unknown metabolites proved to be an order of magnitude longer than those of the parent 
compound or the A-demethyl metabolite. 
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